FDA to ‘rapidly work’ towards emergency use authorization for Pfizer-BioNTech vaccine

The Meals and Drug Administration stated right now that following yesterday’s favourable advisory committee meeting end result about the Pfizer-BioNTech COVID-19 vaccine, it would fast perform towards finalization and issuance of an unexpected emergency use authorization for the COVID-19 vaccine. 

The Food and drug administration gave no unique timeline.

The agency has also notified the U.S. Facilities for Illness Regulate and Avoidance and Operation Warp Velocity, so they can execute their plans for timely vaccine distribution.

Acceptance signifies vaccine distribution would be on Operation Warp Speed’s plan for distribution to entrance-line healthcare staff and vulnerable populations in very long-phrase care facilities by mid-month.

The Food and drug administration advisory committee has scheduled another meeting to review the Moderna vaccine on Thursday, December 17.

See our continuing vaccine coverage right here:

Pfizer-BioNTech vaccine receives Food and drug administration advisory committee acceptance

CMS features advice in billing Medicare for COVID-19 antibody remedy

1000’s in the United Kingdom are the first to acquire Pfizer COVID-19 vaccine

Eli Lilly and UnitedHealth Group partner on COVID-19 antibody remedy for significant-risk persons

Operation Warp Velocity is hunting to begin distributing COVID-19 vaccine by mid-month

Moderna seeks regulatory authorization for its COVID-19 vaccine

HHS will start off allocating Regeneron’s COVID-19 therapeutic this week

HHS partners with chain and unbiased pharmacies to boost access to upcoming COVID-19 vaccines

COVID-19 vaccine distribution will start off in just 24 several hours of an unexpected emergency use authorization

Moderna vaccine prospect displays ninety four.5{744e41c82c0a3fcc278dda80181a967fddc35ccb056a7a316bb3300c6fc50654} efficacy in opposition to COVID-19

Pfizer touts new COVID-19 vaccine, contacting it ’90{744e41c82c0a3fcc278dda80181a967fddc35ccb056a7a316bb3300c6fc50654} effective’

Medicare beneficiaries can get monoclonal antibody COVID-19 treatments at no price

Food and drug administration grants unexpected emergency use authorization for Eli Lilly antibody remedy for COVID-19

Twitter: @SusanJMorse
Email the author: [email protected]